Charcoal haemoperfusion has been advocated as a means of removing 8 aminolaevulinic acid, which accumulates in attacks of acute intermittent porphyria. A woman presented with acute intermittent porphyria unresponsive to conventional treatment and with pain that was difficult to control. Charcoal haemoperfusion was performed in series with haemodialysis for two hours daily on four consecutive days. Although during this treatment serum and urinary concentrations of 3 aminolaevulinic acid and porphobilinogen were considerably reduced, they had returned to pretreatment values 24 hours after the end of treatment. Abdominal pain was not relieved.
Introduction
Acute intermittent porphyria presents as severe attacks of abdominal pain, sometimes accompanied by neuropathy and mental disturbance, and may persist for months. It results from a hereditary partial block in the pathway of haem biosynthesis due to deficiency of uroporphobilinogen synthase. In clinical attacks there is an accumulation of the porphyrin precursors 8 aminolaevulinic acid and porphobilinogen which are formed before the block, appear in the blood, and are excreted in the urine. The After gaining written informed consent we performed haemoperfusion with a 300 g activated charcoal column (Adsorba 300; Gambro, Sweden) in series with haemodialysis for two hours daily on four consecutive days. The figure shows the effect of this treatment on mean daily pain scores (assessed on a visual analogue scale every four hours) and serum and urinary concentrations of 8 aminolaevulinic acid and porphobilinogen. Haemoperfusion caused considerable thrombocytopenia, as previously reported.' The platelet count, measured daily, fell from 204 x 109/l to 161 x 10'/l after the first haemoperfusion and then steadily to 75 x 109/1 after the fourth haemoperfusion, when treatment was stopped; but it had returned to normal by the seventh day after perfusion.
Discussion
The link between the biochemical disturbance of synthesis of haem and the pathogenesis of pain in acute intermittent porphyria has remained speculative.3 A strong association exists, In our study haemoperfusion with activated charcoal columns coupled with haemodialysis considerably reduced serum concentrations of 8 aminolaevulinic acid and porphobilinogen with a concomitant decrease in urinary porphyrin precursors; but serum concentrations had returned to pretreatment values within 24 hours and abdominal pain was not relieved after four days' treatment. We cannot exclude the possibility that a longer course of treatment might have had a more favourable outcome, but this seems unlikely in view of the rapid rebound of serum concentrations of 8 aminolaevulinic acid after each haemoperfusion. Furthermore, the resulting thrombocytopenia might present a major limiting factor to such treatnent.
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Introduction
Cardiopulmonary bypass is thought to activate complement.1 2 The importance of this lies in the postoperative changes seen in lung function' 3 and possibly in changes in myocardial function.4 5 Attempts have been made to measure complement activation by changes in haemolytic activity (CH5),2 6 7 by aggregation of white cell polymorphs by activated complement components8 and by measurement of absolute concentrations of complement.7 Complement activation has been measured in vivo by crossed immunoelectrophoresis for C3c,6 10 by an assay for C3d using radial immunodiffusion,9 11 and by radioimmunoassay of C3a and C5a." Earlier workers detected varying amounts of complement activation in the bypass period. Recent work has thrown doubt on these findings since an assay of C3d9 11 failed to confirm complement activation in the bypass period. The use of either corticosteroid3 413 or pulsatile flow during cardiopulmonary bypass1 15 is controversial.
